1921
Volume 66, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

The aim of this study was to evaluate the bioavailability of artesunate (ARTS) and dihydroartemisinin (DHA). When the single-pass isolated perfused rat liver model was used, the hepatic bioavailability of ARTS (39 microM) was 0.20 and the bioavailability of DHA in ARTS and DHA (35 microM) perfusions was 0.12 and 0.11, respectively. Thus, the combined bioavailability of ARTS and DHA in the ARTS perfusions (0.32) was three-fold higher than the bioavailability of DHA. In the human study, eight healthy volunteers were randomized to receive oral ARTS (135 mg; 352 micromol) or oral DHA (120 mg; 422 micromol). The area under the curve (AUC(0-6 hr)) of DHA following ARTS (2.9 micromol x hr/L) was higher than the AUC(0-6 hr) of DHA following DHA administration (1.2 micromol x hr/L; P < 0.005). The dose-corrected relative oral bioavailability of DHA for DHA compared with ARTS was 43%. Thus, the use of conventional oral dosage regimens of ARTS appears preferable to oral administration of DHA.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2002.66.130
2002-02-01
2017-09-23
Loading full text...

Full text loading...

http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2002.66.130
Loading

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error